Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralymphatic Immunotherapy with Tyrosine S for Allergic Rhinitis
NCT02665754Phase 1Completed
- Sponsor
- Gachon University Gil Medical Center
- Start
- Jul 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of tyrosine in allergic rhinitis (AR) (2 arms), sponsored by Gachon University Gil Medical Center. Primary endpoint: Rhinoconjunctivitis Quality of Life Questionnaire at 4 months. Started Jul 2016; status: completed.
02
Drugs
tyrosine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02665754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02665754.